July 9-14, 2017
São Paulo, Brazil
Charles Mowbray, Head of Discovery, DNDi presented on drug discovery for neglected diseases.
KEMRI Annual Scientific and Health Conference
February 8-10, 2017
Gina Ouattara, Project Coordinator for HIV/HCV, and Kevin Onyango, Project Coordinator for Mycetoma, both from the DNDi Africa office, presented at the event.
Our staff, partners, and stakeholders share their highlights from 2016.
WuXi App Tec [1 December, 2016]
“Harnessing science for the most neglected diseases – A chat with Charles Mowbray, Ph.D., Head of Drug Discovery, DNDi“
The implementation Project for Chagas disease in Colombia is moving forward. After an epidemiological analysis, the partners confirmed the change of the diagnostic algorithm for the country’s pilot projects. With the new algorithm, positive cases for Chagas are confirmed by a simpler procedure test.
devex [18 July, 2016]
“Bringing medicines to the world”
As the International AIDS Conference kicks off in Durban, the Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing ‘4-in-1’ fixed-dose combinations using the World Health Organization (WHO) recommended treatment regimen for infants and young children. DNDi’s update also discusses some promising developments for treatment for children living with both HIV and tuberculosis (TB).
[Paris, France – Le 06 juillet 2016]
La Fondation Mérieux, l’Inserm, l’Institut Pasteur, Réseau CANOPE, MSF, Universcience, le DNDi… Les principaux acteurs français de la lutte contre les maladies infectieuses présentent la série et le webdocumentaire Grandes Tueuses, disponibles en ligne dès maintenant. Conçues comme un outil de sensibilisation pour le grand public et les acteurs de terrain, les 70 vidéos décrivent 14 grandes problématiques de santé publique et sont en open data, en libre accès et libre utilisation. En complément, le webdocumentaire est présenté sur le site d’Allô Docteurs.
European & Developing Countries Clinical Trials Partnership
November 6-9, 2016
DNDi participated in the event.
The East African [18 June, 2016]
“Easy-to-swallow anti-AIDS drug for East Africa’s children”
Daily Monitor [18 June, 2016]
“HIV-positive children get ‘sweet’ ARVs”
Agência Brasil [6 June, 2016]
“Pesquisadores discutem formas de incentivar estudo de doenças negligenciadas” – “Researchers want to encourage the study of neglected diseases”
Pharmaceutical Sciences: Improving World Health
September 5-7, 2016
Steve Robinson, Head of Pharmaceutical Development at DNDi, presented on neglected diseases.
[1 June 2016 – Tokyo, Japan]
Non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) welcomes the G7-related announcement from the Government of Japan to replenish the Global Health Innovative Technology Fund (GHIT Fund) for research and development to combat infectious diseases including neglected tropical diseases.
IP Watch [28 May 2016]
“Reactions to WHA Resolution on R&D financing generally positive”
IP Watch [24 May 2016]
“Global health R&D under debate at World Health Assembly”
21st International AIDS Conference
July 18-22, 2016
Durban, South Africa
DNDi, CHAI, UNITAID, and NEPHAK held an AIDS 2016 Satellite Session to share practical and programmatic experience developing and introducing new paediatric ARV formulations.
June 6-8, 2016
Rio de Janeiro, Brazil
DNDi Latin America organized a series of events with conferences, discussions and meetings. International scientists, product developers, policy-makers, and civil society organizations, participated in the events in order to do the best science for the most neglected.